These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24360150)

  • 1. Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy.
    Hara Y; Kawasaki N; Hirano K; Hashimoto Y; Adachi J; Watanabe S; Tomonaga T
    Orphanet J Rare Dis; 2013 Dec; 8():197. PubMed ID: 24360150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-γ in patients with triglyceride deposit cardiomyovasculopathy.
    Hirano K; Tanaka T; Ikeda Y; Yamaguchi S; Zaima N; Kobayashi K; Suzuki A; Sakata Y; Sakata Y; Kobayashi K; Toda T; Fukushima N; Ishibashi-Ueda H; Tavian D; Nagasaka H; Hui SP; Chiba H; Sawa Y; Hori M
    Biochem Biophys Res Commun; 2014 Jan; 443(2):574-9. PubMed ID: 24332944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy.
    Takagi A; Ikeda Y; Kobayashi K; Kobayashi K; Ikeda Y; Kozawa J; Miyauchi H; Li M; Hashimoto C; Hara Y; Yamaguchi S; Suzuki A; Toda T; Nagasaka H; Hirano KI
    Biochem Biophys Res Commun; 2018 Jan; 495(1):646-651. PubMed ID: 29146190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.
    Li M; Hirano KI; Ikeda Y; Higashi M; Hashimoto C; Zhang B; Kozawa J; Sugimura K; Miyauchi H; Suzuki A; Hara Y; Takagi A; Ikeda Y; Kobayashi K; Futsukaichi Y; Zaima N; Yamaguchi S; Shrestha R; Nakamura H; Kawaguchi K; Sai E; Hui SP; Nakano Y; Sawamura A; Inaba T; Sakata Y; Yasui Y; Nagasawa Y; Kinugawa S; Shimada K; Yamada S; Hao H; Nakatani D; Ide T; Amano T; Naito H; Nagasaka H; Kobayashi K;
    Orphanet J Rare Dis; 2019 Jun; 14(1):134. PubMed ID: 31186072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Criteria 2020 for Triglyceride Deposit Cardiomyovasculopathy.
    Kobayashi K; Sakata Y; Miyauchi H; Ikeda Y; Nagasawa Y; Nakajima K; Shimada K; Kozawa J; Hao H; Amano T; Yoshida H; Inaba T; Hashimoto C; Hirano KI;
    Ann Nucl Cardiol; 2020; 6(1):99-104. PubMed ID: 37123492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Tricaprin on Cardiac Proteome in a Mouse Model for Triglyceride Deposit Cardiomyovasculopathy.
    Hara Y; Zhang B; Suzuki A; Yamaguchi S; Adachi J; Tomonaga T; Yasunaga S; Saku K; Aoyama T; Hirano KI
    J Oleo Sci; 2020 Nov; 69(12):1569-1577. PubMed ID: 33177279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-MRS to evaluate improved triglyceride accumulation in idiopathic triglyceride deposit cardiomyovasculopathy after CNT-01 (tricaprin/trisdecanion) administration.
    Aikawa T; Sai E; Kudo A; Kawaguchi YO; Takamura K; Hiki M; Yokoyama T; Miyazaki T; Fujimoto S; Shimada K; Hirano KI; Daida H; Minamino T
    Endocrinol Diabetes Metab Case Rep; 2023 Apr; 2023(2):. PubMed ID: 37096980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
    Kaneko K; Kuroda H; Izumi R; Tateyama M; Kato M; Sugimura K; Sakata Y; Ikeda Y; Hirano K; Aoki M
    Neuromuscul Disord; 2014 Jul; 24(7):634-41. PubMed ID: 24836204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricaprin Rescues Myocardial Abnormality in a Mouse Model of Triglyceride Deposit Cardiomyovasculopathy.
    Suzuki A; Yamaguchi S; Li M; Hara Y; Miyauchi H; Ikeda Y; Zhang B; Higashi M; Ikeda Y; Takagi A; Nagasaka H; Kobayashi K; Magata Y; Aoyama T; Hirano KI
    J Oleo Sci; 2018 Aug; 67(8):983-989. PubMed ID: 30012901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients.
    Onishi T; Nakano Y; Hirano KI; Nagasawa Y; Niwa T; Tajima A; Ishii H; Takahashi H; Sakurai S; Ando H; Takashima H; Amano T
    Heart; 2021 Jan; 107(2):127-134. PubMed ID: 32998957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Triglyceride deposit cardiomyovasculopathy].
    Hirano K
    Nihon Rinsho; 2013 Sep; 71(9):1676-80. PubMed ID: 24205734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Perspectives for the Diagnosis of Idiopathic Triglyceride Deposit Cardiomyovasculopathy.
    Miyauchi H; Iimori T; Hoshi K; Ohyama M; Hirano KI; Kobayashi Y
    Ann Nucl Cardiol; 2020; 6(1):33-38. PubMed ID: 37123494
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel homozygous missense mutation in
    Hara Y; Ikeda Y; Kimura H; Shimamoto S; Ishikawa M; Kobayashi K; Nagasaka H; Shimoyama H; Hirano KI
    Mol Genet Metab Rep; 2023 Mar; 34():100960. PubMed ID: 36846631
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Miyauchi H; Hirano KI; Nakano Y; Shimada K; Nishikawa M; Yamamoto H; Nakamura A; Miyake A; Aoshima C; Fujimoto S; Nakatani D; Yamada T; Amano T; Nakajima K
    Ann Nucl Cardiol; 2022; 8(1):67-75. PubMed ID: 36540180
    [No Abstract]   [Full Text] [Related]  

  • 15. Triglyceride Deposit Cardiomyovasculopathy with Massive Myocardial Triglyceride which Was Proven Using Proton-magnetic Resonance Spectroscopy.
    Sai E; Shimada K; Aikawa T; Aoshima C; Takamura K; Hiki M; Yokoyama T; Miyazaki T; Fujmoto S; Konishi H; Hirano KI; Daida H; Minamino T
    Intern Med; 2021 Apr; 60(8):1217-1220. PubMed ID: 33162485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods of calculating
    Chen Z; Nakajima K; Hirano KI; Kamiya T; Yoshida S; Saito S; Kinuya S
    Ann Nucl Med; 2022 Nov; 36(11):986-997. PubMed ID: 36155888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outside-in signaling by femoral cuff injury induces a distinct vascular lesion in adipose triglyceride lipase knockout mice.
    Noguchi H; Yamada S; Hirano KI; Yamaguchi S; Suzuki A; Guo X; Zaima N; Li M; Kobayashi K; Ikeda Y; Nakayama T; Sasaguri Y
    Histol Histopathol; 2021 Jan; 36(1):91-100. PubMed ID: 33231284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral leukocyte anomaly detected with routine automated hematology analyzer sensitive to adipose triglyceride lipase deficiency manifesting neutral lipid storage disease with myopathy/triglyceride deposit cardiomyovasculopathy.
    Suzuki A; Nagasaka H; Ochi Y; Kobayashi K; Nakamura H; Nakatani D; Yamaguchi S; Yamaki S; Wada A; Shirata Y; Hui SP; Toda T; Kuroda H; Chiba H; Hirano KI
    Mol Genet Metab Rep; 2014; 1():249-253. PubMed ID: 27896096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SILAC quantitative proteomics analysis of ivermectin-related proteomic profiling and molecular network alterations in human ovarian cancer cells.
    Li N; Li J; Desiderio DM; Zhan X
    J Mass Spectrom; 2021 Jan; 56(1):e4659. PubMed ID: 33047383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.